Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.
Med Sci Monit. 2022 Dec 1;28:e939088. doi: 10.12659/MSM.939088.
The COVID-19 pandemic, climate change, increased resistance to antifungal drugs, and an increased number of immunocompromised patients have driven a recent global surge in pathogenic fungal infections, including aspergillosis, candidiasis, and mucormycosis. On 25 October 2022, the World Health Organization (WHO) released a list of 19 fungal priority pathogens identified as having the greatest threat to public health. The WHO Fungal Priority Pathogens List represents the first global response to identify and prioritize fungal pathogens and their impact on global public health and to consider the unmet research and development needs. The WHO has grouped the priority fungal pathogens into those of critical, high, and medium priority. This Editorial aims to highlight the importance of identifying and prioritizing fungal pathogens and identifying emerging fungal pathogens and the global factors driving changing patterns of infection.
COVID-19 大流行、气候变化、抗真菌药物耐药性的增加以及免疫功能低下患者人数的增加,导致了近期全球致病性真菌感染(包括曲霉病、念珠菌病和毛霉病)的激增。2022 年 10 月 25 日,世界卫生组织(WHO)发布了一份清单,列出了被认为对公共卫生构成最大威胁的 19 种真菌优先病原体。这份 WHO 真菌优先病原体清单代表了首次针对识别和优先考虑真菌病原体及其对全球公共卫生的影响,并考虑到未满足的研究和开发需求的全球应对措施。世卫组织将优先真菌病原体分为关键、高和中等优先级。这篇社论旨在强调确定和优先考虑真菌病原体以及确定新出现的真菌病原体和驱动感染模式变化的全球因素的重要性。